Insider Transactions in Q4 2021 at Avalo Therapeutics, Inc. (AVTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Schond L. Greenway CFO |
BUY
Open market or private purchase
|
Direct |
2,231
+36.49%
|
$2,231
$1.57 P/Share
|
|
Dec 10
2021
|
Garry Arthur Neil CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
4,267
+4.75%
|
$4,267
$1.57 P/Share
|
|
Dec 10
2021
|
James Archie Harrell Jr Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
1,093
+2.89%
|
$1,093
$1.57 P/Share
|
|
Dec 10
2021
|
Christopher Ryan Sullivan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
955
+9.59%
|
$955
$1.57 P/Share
|
|
Dec 10
2021
|
H Jeffrey Wilkins Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
6,371
+16.03%
|
$6,371
$1.57 P/Share
|